Stemline Therapeutics, Inc. Operating Income 2013-2020 | STML

Stemline Therapeutics, Inc. operating income from 2013 to 2020. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Stemline Therapeutics, Inc. Annual Operating Income
(Millions of US $)
2019 $-79
2018 $-86
2017 $-69
2016 $-39
2015 $-38
2014 $-29
2013 $-24
2012 $-6
2011 $-3
2010 $-2
2009 $-2
Stemline Therapeutics, Inc. Quarterly Operating Income
(Millions of US $)
2020-03-31 $-22
2019-12-31 $-18
2019-09-30 $-15
2019-06-30 $-17
2019-03-31 $-28
2018-12-31 $-27
2018-09-30 $-21
2018-06-30 $-19
2018-03-31 $-19
2017-12-31 $-22
2017-09-30 $-16
2017-06-30 $-16
2017-03-31 $-15
2016-12-31 $-10
2016-09-30 $-10
2016-06-30 $-10
2016-03-31 $-9
2015-12-31 $-10
2015-09-30 $-9
2015-06-30 $-10
2015-03-31 $-8
2014-12-31 $-7
2014-09-30 $-7
2014-06-30 $-6
2014-03-31 $-9
2013-12-31 $-8
2013-09-30 $-6
2013-06-30 $-5
2013-03-31 $-5
2012-12-31 $-1
2012-09-30 $-2
2012-06-30 $-2
2012-03-31 $-1